Cite Filings / XLO / 0001193125-26-048934
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Xilio Therapeutics, Inc. · Filed 2026-02-12 · Acc 0001193125-26-048934

Documents 1

  • 424B5 Prospectus , d74783d424b5.htm

Around this filing

  • 2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-02-17 4 Options or other derivatives
  • 2026-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-02-12 8-K Material agreement · Regulation FD disclosure
  • 2026-02-12 424B5 Prospectus
  • 2026-02-12 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-02-11 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d74783d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…